Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Parasites alter the pathological phenotype of lupus nephritis.

Miyake K, Adachi K, Watanabe M, Sasatomi Y, Ogahara S, Abe Y, Ito K, Dan Justin YK, Saito T, Nakashima H, Hamano S.

Autoimmunity. 2014 Dec;47(8):538-47. doi: 10.3109/08916934.2014.929669.

2.

Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1).

Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, Akahoshi M, Katafuchi R, Hirakata H, Harada M, Hamano S, Nakashima H, Yoshida H.

J Immunol. 2005 Dec 1;175(11):7185-92.

3.

Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis.

Igawa T, Nakashima H, Sadanaga A, Masutani K, Miyake K, Shimizu S, Takeda A, Hamano S, Yoshida H.

Mod Rheumatol. 2009;19(1):33-41. doi: 10.1007/s10165-008-0117-1.

PMID:
18779924
4.

CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.

Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.

J Immunol. 2009 Oct 1;183(7):4693-704. doi: 10.4049/jimmunol.0802626.

5.

Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.

Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.

Arthritis Rheum. 2002 Nov;46(11):3083-95.

6.
7.

Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice.

Ito T, Seo N, Yagi H, Ohtani T, Tokura Y, Takigawa M, Furukawa F.

J Dermatol Sci. 2002 Apr;28(3):198-210.

PMID:
11912007
9.

Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.

J Clin Invest. 1996 Apr 1;97(7):1597-604.

11.

Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.

Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.

J Immunol. 2011 Sep 15;187(6):3413-21. doi: 10.4049/jimmunol.1101125.

12.
13.
14.

Function of the Th17/interleukin-17A immune response in murine lupus nephritis.

Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.

Arthritis Rheumatol. 2015 Feb;67(2):475-87. doi: 10.1002/art.38955.

15.

Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.

Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.

J Rheumatol. 2010 Jan;37(1):60-70. doi: 10.3899/jrheum.090194.

PMID:
19955044
16.

Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.

Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M.

Eur J Immunol. 2005 May;35(5):1510-20.

17.
18.

Predominance of Th1 immune response in diffuse proliferative lupus nephritis.

Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, Fukuda K, Kanai H, Nakashima H, Otsuka T, Hirakata H.

Arthritis Rheum. 2001 Sep;44(9):2097-106.

19.
20.

Th subset balance in lupus nephritis.

Miyake K, Akahoshi M, Nakashima H.

J Biomed Biotechnol. 2011;2011:980286. doi: 10.1155/2011/980286. Review.

Items per page

Supplemental Content

Support Center